Google DeepMind's AlphaGenome 2 maps genetic effects at the single-cell level
New AI model predicts how DNA variants affect specific cell types, potentially accelerating disease research and drug development.
New AI model predicts how DNA variants affect specific cell types, potentially accelerating disease research and drug development.
AlphaGenome 2 identifies how DNA variants affect specific cell types, doubling detection of gene-expression-altering mutations across 68 tissues.
Hugging Face released Carbon-X, an open-source model combining DNA and natural language to enable conversational queries about genetic effects and mutations.
Foundation models trained on DNA sequences excel at prediction but fail at explanation, leaving biologists unable to understand why their forecasts work.
OpenAI released GeneBench-Pro, a benchmark of 10 case studies designed to evaluate AI models on practical genomics reasoning tasks.
OpenAI introduces GeneBench-Pro, a 129-problem benchmark measuring whether AI models can make higher-order scientific judgments in genomics and translational medicine.
Google DeepMind's AI system helps biologists identify genetic pathways that reverse cellular senescence, validating novel hypotheses in weeks rather than months.